Form 4: Director Scott Gottlieb Receives Illumina Stock Grant

Illumina, Inc. director Scott Gottlieb was granted 2,072 restricted stock units as part of his director compensation.

Summary

• Director Scott Gottlieb acquired 2,072 shares of Illumina, Inc. (ILMN) common stock.
• The transaction occurred on May 21, 2026, in the form of a restricted stock unit (RSU) grant.
• The shares were valued at $144.83 per share.
• Following this transaction, the director's total beneficial ownership increased to 14,795 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or strategy.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified; this is a standard director compensation disclosure.

Risks

• Vesting of the restricted stock units is contingent upon the director's continued service on the board until the day prior to the annual meeting.

Future Outlook

The restricted stock units will vest in full on the day prior to the company's annual stockholders' meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants for board members are a standard corporate governance practice in the biotechnology sector to ensure long-term alignment between leadership and shareholder value.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices at large-cap life sciences companies like Thermo Fisher Scientific and Danaher Corporation.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of the 2,072 restricted stock units prior to the next annual stockholders' meeting.

Key Dates

Keywords

Illumina, ILMN, Scott Gottlieb, Form 4, Insider Trading, Director Compensation, Biotechnology